Valued at USD 4.89 billion in 2024, the surgical sutures market is projected to reach USD 5.14 billion in 2025 and USD 8.32 billion by 2034, growing at a CAGR of 5.5% during the forecast period 2025–2034. North America was the largest regional market in 2024. Key players include Ethicon (a Johnson & Johnson company), Medtronic PLC, B. Braun SE, Advanced Medical Solutions Group PLC, Teleflex Incorporated, Smith & Nephew PLC, and CONMED Corporation.

Surgical Sutures Market Overview

The surgical sutures market encompasses the materials and devices medical professionals use to close wounds or join tissues after surgery or injury. Demand is driven chiefly by rising global surgical volumes, which reflect an aging population and the growing prevalence of chronic diseases. Polaris Market Research cites a study projecting that the population aged 65 and above would grow by 53.2% between 2001 and 2020, a group with higher surgical utilization across specialties. The report also points to high surgical volumes in India as evidence of rising demand in developing regions, where chronic diseases and trauma injuries contribute to procedure growth.

Innovation in Suture Materials and Technologies

Material innovation is the second major growth force. Developers are introducing biodegradable options and antimicrobial sutures designed to improve wound healing, lower infection risk, and give surgeons better handling. A 2024 review cited in the report describes modified antimicrobial sutures as a promising approach to combating infections at the wound site, and notes that drug-eluting designs can release medication gradually during healing. Regulatory milestones reinforce the trend: in September 2023, Genesis MedTech received approval from China's NMPA to launch antibacterial absorbable sutures intended to enhance healing and reduce infection risk.

Browse Full Insights: https://www.polarismarketresearch.com/industry-analysis/surgical-sutures-market

Surgical Sutures Market by Type: Absorbable and Non-Absorbable

The absorbable sutures segment held the larger share in 2024. These products break down naturally in the body, removing the need for a second procedure to take them out, which makes them well suited to internal wound closure where long-term support is not required. The report notes their widespread adoption across general, gynecological, and ophthalmic procedures.

The non-absorbable sutures segment is anticipated to grow at a higher rate during the forecast period. Made from materials the body cannot break down, non-absorbable sutures provide permanent tissue support, which is essential in cardiovascular surgery and in the repair of slow-healing tissues.

Surgical Sutures Market by Filament: Multifilament and Monofilament

Multifilament sutures accounted for the larger share in 2024. Braided or twisted from multiple fine strands, they offer excellent tensile strength, flexibility, and secure knot tying, making them preferred in high-tension areas such as cardiovascular and orthopedic procedures.

Monofilament sutures are expected to register the highest growth rate. Their single, smooth strand reduces tissue drag and lowers infection risk because there are no interstices in which bacteria can harbor. Minimal tissue reaction supports patient healing and is driving increasing use in plastic surgery and ophthalmology.

Regional and Competitive Landscape

North America led the surgical sutures market in 2024, supported by advanced healthcare infrastructure, high healthcare spending, and a strong emphasis on reducing surgical site infections. Asia Pacific is emerging as a key growth region, propelled by improving healthcare infrastructure, higher healthcare expenditure, and large patient pools in China and India. Competition centers on product differentiation through advanced materials, specialized coatings, and user-friendly designs, alongside pricing strategies and extensive distribution networks. In August 2023, Healthium Medtech launched TRUMAS, a suture line developed for the complexities of suturing in minimally invasive procedures.

Strategic Outlook for B2B Stakeholders

With the market projected to reach USD 8.32 billion by 2034, manufacturers, distributors, and hospital procurement teams should track the contrast between the larger absorbable and multifilament segments and the faster-growing non-absorbable and monofilament segments. Portfolio breadth across material, filament, and infection-control features will remain central to competitive positioning.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market